insights_auto
Kodėl „RHHBF“ padidėjo 4,76%?
Įsigilintichevron_right
RHHBF:OTCMKTS
F. Hoffmann-La Roche
442,97 USD
arrow_upward
+4,76%(+20,12) 1 D.
10-09, 16:00:00 GMT−4 · USD
search
Visi simboliai
| Simbolis | Kaina | Keisti | Pokytis, % |
|---|
insights_autoGeneruojamos svarbiausios „RHHBF“ įžvalgos...
Atidaryti
463,14 USD
Aukšta
463,14 USD
Žema
421,66 USD
Rinkos kapitalizacija
349,40 mlrd.
Vid. kiekis
63,00
Apimtis
39,00
P/E santykis
192,63
52 sav. aukšta
514,08 USD
52 sav. žema
301,27 USD
Pajamos iš vienos akcijos
2,30 USD
Beta
0,45
Neapmokėtos akcijos
106,69 mln.
Darbuotojų skaičius
113 tūkst.
Atidaryti
463,14 USD
Aukšta
463,14 USD
Žema
421,66 USD
Rinkos kapitalizacija
349,40 mlrd.
Vid. kiekis
63,00
Apimtis
39,00
P/E santykis
192,63
52 sav. aukšta
514,08 USD
52 sav. žema
301,27 USD
Pajamos iš vienos akcijos
2,30 USD
Beta
0,45
Neapmokėtos akcijos
106,69 mln.
Darbuotojų skaičius
113 tūkst.
Naujienų istorijos
Iš žiniatinklio šaltinių ir naujienų partnerių
Stock Titan
·
prieš 4 valandas
About 20% with eye swelling progress to lasting blindness within 3 years. Roche's test drug showed yearlong vision gains.
AD HOC NEWS
·
prieš 18 valandų
Roche Holding stock last at EUR 378.33 on Tradegate
Yahoo Finance
·
prieš 1 mėnesį
Top Stock Reports for Berkshire Hathaway, Roche & RTX
Profilis
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
Apie „F. Hoffmann-La Roche“
Generalinis direktoriusThomas Schinecker
Darbuotojai113 tūkst.
Įkurta1896-10-01
Pagrindinė būstinėBazelis, Bazelio miestas, Šveicarija
Sektorius-
Svetainėroche.com